Medela Potentia Tbk PT

Medela Potentia Tbk PT maintains a strong liquidity position, with a current ratio of 1.76, indicating that it has sufficient short-term assets to cover its short-term liabilities. The company also holds cash and equivalents of 122.6 billion IDR, which supports its operational flexibility and financial stability. The debt-to-equity ratio is 0.03, suggesting a conservative capital structure with minimal reliance on debt financing. The company's profitability is reflected in its return on equity (ROE) of 12.92% and return on assets (ROA) of 5.96%, both of which are strong indicators of efficient asset utilization and effective management of shareholder capital. These metrics suggest that Medela Potentia Tbk PT is generating solid returns relative to its equity and total assets, which is favorable compared to the industry norms for pharmaceutical companies. Geographically and segment-wise, the company's revenue is primarily concentrated in Indonesia, with a significant portion derived from its domestic market. The company's business is largely driven by its over-the-counter (OTC) pharmaceutical products, which constitute the majority of its revenue. There is no significant diversification across international markets or product lines, which could expose the company to regional economic fluctuations. The company's growth trajectory is supported by a strong operating cash flow of 521.5 billion IDR and a free cash flow of 129.2 billion IDR, which provides the financial flexibility to fund operations, invest in growth opportunities, and potentially return value to shareholders. The capital expenditure of -219.2 billion IDR indicates that the company is not currently investing heavily in new infrastructure or expansion projects, which may suggest a focus on maintaining existing operations rather than aggressive growth. The risk assessment for Medela Potentia Tbk PT indicates a low level of liquidity and dilution risk, with no immediate filing-based flags detected. The company's conservative capital structure and strong cash reserves reduce the likelihood of near-term financial distress or equity dilution. The absence of significant debt and the presence of a robust cash position further support the company's financial resilience. Recent events and filings do not indicate any material changes in the company's financial or operational status. The company has not issued any new shares or announced significant capital-raising activities in the recent period, and there are no notable regulatory or legal challenges reported in the latest filings.